Literature DB >> 10427987

Relaxin favors the development of activated human T cells into Th1-like effectors.

M P Piccinni1, D Bani, L Beloni, C Manuelli, C Mavilia, F Vocioni, M Bigazzi, T B Sacchi, S Romagnani, E Maggi.   

Abstract

Differentiation of naive CD4+ helper T (Th) cells into Th1 or Th2 effectors, as characterized by their opposite pattern of cytokine production, can be influenced by several factors, including hormones. In this study, we demonstrate that porcine relaxin, at concentrations ranging from 10(-10) to 10(-6) M, favors the in vitro development of human antigen-specific T cells into Th1-like effectors and enhances both IFN-gamma mRNA expression and IFN-gamma production by established human T cell clones. The promoting effect of relaxin on the development of IFN-gamma-producing cells was not due to a relaxin-induced release of IL-12 and/or IFN-alpha by antigen-presenting cells. These results suggest that relaxin may contribute to the regulation of the immune homeostasis during pregnancy and may also play some role in counteracting Th2-dominated disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10427987     DOI: 10.1002/(SICI)1521-4141(199907)29:07<2241::AID-IMMU2241>3.0.CO;2-E

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway.

Authors:  E Masini; G Zagli; J F Ndisang; M Solazzo; P F Mannaioni; D Bani
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

2.  Variations in cytokine mRNA expression during normal human pregnancy.

Authors:  N Kruse; M Greif; N F Moriabadi; L Marx; K V Toyka; P Rieckmann
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  T helper cell mediated-tolerance towards fetal allograft in successful pregnancy.

Authors:  Marie-Pierre Piccinni; Letizia Lombardelli; Federica Logiodice; Ornela Kullolli; Sergio Romagnani; Philippe Le Bouteiller
Journal:  Clin Mol Allergy       Date:  2015-06-10

4.  Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice.

Authors:  Xiaodong Mu; Maria L Urso; Kiley Murray; Freddie Fu; Yong Li
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

Review 5.  Does a higher number of siblings protect against the development of allergy and asthma? A review.

Authors:  W Karmaus; C Botezan
Journal:  J Epidemiol Community Health       Date:  2002-03       Impact factor: 3.710

6.  Quercetin and Bornyl Acetate Regulate T-Lymphocyte Subsets and INF-γ/IL-4 Ratio In Utero in Pregnant Mice.

Authors:  Xiaodan Wang; Aituan Ma; Wanyu Shi; Meiying Geng; Xiuhui Zhong; Yantao Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-29       Impact factor: 2.629

7.  Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice.

Authors:  Alessandra Bitto; Natasha Irrera; Letteria Minutoli; Margherita Calò; Patrizia Lo Cascio; Paolo Caccia; Gabriele Pizzino; Giovanni Pallio; Antonio Micali; Mario Vaccaro; Antonino Saitta; Francesco Squadrito; Domenica Altavilla
Journal:  Clin Sci (Lond)       Date:  2013-12       Impact factor: 6.124

Review 8.  Cardiac anaphylaxis: pathophysiology and therapeutic perspectives.

Authors:  Daniele Bani; Silvia Nistri; Pier Francesco Mannaioni; Emanuela Masini
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.919

Review 9.  Biology of primate relaxin: a paracrine signal in early pregnancy?

Authors:  Eric S Hayes
Journal:  Reprod Biol Endocrinol       Date:  2004-06-16       Impact factor: 5.211

10.  Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain.

Authors:  Claudia Binder; Eugenia Chuang; Christina Habla; Annalen Bleckmann; Matthias Schulz; Ross Bathgate; Almuth Einspanier
Journal:  Clin Exp Metastasis       Date:  2013-08-21       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.